12 Health Care Stocks Moving In Thursday's Intraday Session
$APYX
$CMAX
$CRVO
$EIGR
Medical/Dental Instruments
Health Care
Hospital/Nursing Management
Health Care
Gainers
- Yield10 Bioscience (NASDAQ:YTEN) shares moved upwards by 71.5% to $0.42 during Thursday's regular session. The market value of their outstanding shares is at $4.9 million.
- Monogram Orthopaedics (NASDAQ:MGRM) stock rose 28.74% to $2.15. The market value of their outstanding shares is at $68.0 million. As per the press release, Q4 earnings came out 4 days ago.
- X4 Pharmaceuticals (NASDAQ:XFOR) stock increased by 21.61% to $1.24. The market value of their outstanding shares is at $207.5 million. As per the news, the Q4 earnings report came out today.
- Eiger BioPharmaceuticals (NASDAQ:EIGR) shares rose 17.78% to $6.33. The market value of their outstanding shares is at $9.3 million.
- CareMax (NASDAQ:CMAX) stock increased by 17.18% to $6.41. The company's market cap stands at $24.3 million. The company's, Q4 earnings came out 3 days ago.
- NextCure (NASDAQ:NXTC) shares rose 17.01% to $1.65. The market value of their outstanding shares is at $46.0 million.
Losers
- Tourmaline Bio (NASDAQ:TRML) shares decreased by 40.6% to $26.54 during Thursday's regular session. The market value of their outstanding shares is at $680.6 million. The company's, Q4 earnings came out 2 days ago.
- Apyx Medical (NASDAQ:APYX) stock declined by 24.87% to $1.39. The company's market cap stands at $48.1 million. The company's, Q4 earnings came out today.
- Ontrak (NASDAQ:OTRK) shares decreased by 21.43% to $0.25. The market value of their outstanding shares is at $6.8 million.
- SCWorx (NASDAQ:WORX) shares declined by 18.9% to $3.15. The company's market cap stands at $3.8 million.
- Phio Pharma (NASDAQ:PHIO) shares fell 15.52% to $0.9. The market value of their outstanding shares is at $4.1 million.
- CervoMed (NASDAQ:CRVO) stock declined by 14.68% to $22.12. The market value of their outstanding shares is at $136.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
